• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[弱视——弱视治疗的当代策略]

[The lazy eye - contemporary strategies of amblyopia treatment].

作者信息

Sturm V

机构信息

Augenklinik, Universitätsspital Zürich, Zürich.

出版信息

Praxis (Bern 1994). 2011 Feb 16;100(4):229-35. doi: 10.1024/1661-8157/a00442.

DOI:10.1024/1661-8157/a00442
PMID:21328237
Abstract

Amblyopia is a condition of decreased monocular or binocular visual acuity caused by form deprivation or abnormal binocular interaction. Amblyopia is the most common cause of monocular vision loss in children with a prevalence of 2 to 5%. During the last decade, several prospective randomized studies have influenced our clinical management. Based on these studies, optimum refractive correction should be prescribed first. However, most patients will need additional occlusion therapy which is still considered the «gold standard» of amblyopia management. Now much lower doses have been shown to be effective. In moderate amblyopia, penalization with atropine is as effective as patching. New treatment modalities including perceptual learning, pharmacotherapy with levodopa and citicholine or transcranial magnetic stimulation have not yet been widely accepted.

摘要

弱视是一种由形觉剥夺或双眼异常相互作用引起的单眼或双眼视力下降的病症。弱视是儿童单眼视力丧失的最常见原因,患病率为2%至5%。在过去十年中,多项前瞻性随机研究影响了我们的临床管理。基于这些研究,应首先开具最佳的屈光矫正处方。然而,大多数患者需要额外的遮盖疗法,这仍然被认为是弱视治疗的“金标准”。现在已证明低得多的剂量也有效。在中度弱视中,阿托品压抑疗法与遮盖疗法效果相当。包括感知学习、左旋多巴和胞磷胆碱药物治疗或经颅磁刺激在内的新治疗方法尚未被广泛接受。

相似文献

1
[The lazy eye - contemporary strategies of amblyopia treatment].[弱视——弱视治疗的当代策略]
Praxis (Bern 1994). 2011 Feb 16;100(4):229-35. doi: 10.1024/1661-8157/a00442.
2
The treatment of amblyopia: current practice and emerging trends.弱视的治疗:当前实践与新趋势
Graefes Arch Clin Exp Ophthalmol. 2019 Jun;257(6):1061-1078. doi: 10.1007/s00417-019-04254-w. Epub 2019 Jan 31.
3
Atropine vs patching for treatment of moderate amblyopia: follow-up at 15 years of age of a randomized clinical trial.阿托品与遮盖疗法治疗中度弱视的比较:一项随机临床试验15岁时的随访
JAMA Ophthalmol. 2014 Jul;132(7):799-805. doi: 10.1001/jamaophthalmol.2014.392.
4
Clinical trial of patching versus atropine penalization for the treatment of anisometropic amblyopia in older children.大龄儿童屈光参差性弱视遮盖疗法与阿托品压抑疗法的临床试验
J AAPOS. 2008 Oct;12(5):493-7. doi: 10.1016/j.jaapos.2008.03.006. Epub 2008 Jun 5.
5
Comparative efficacy of penalization methods in moderate to mild amblyopia.中度至轻度弱视中惩罚方法的比较疗效
Am J Ophthalmol. 2008 Mar;145(3):562-9. doi: 10.1016/j.ajo.2007.10.029. Epub 2008 Jan 22.
6
A randomized trial of atropine vs patching for treatment of moderate amblyopia: follow-up at age 10 years.阿托品与眼罩治疗中度弱视的随机试验:10岁时的随访
Arch Ophthalmol. 2008 Aug;126(8):1039-44. doi: 10.1001/archopht.126.8.1039.
7
Randomized trial of treatment of amblyopia in children aged 7 to 17 years.7至17岁儿童弱视治疗的随机试验。
Arch Ophthalmol. 2005 Apr;123(4):437-47. doi: 10.1001/archopht.123.4.437.
8
Full-time atropine, intermittent atropine, and optical penalization and binocular outcome in treatment of strabismic amblyopia.治疗斜视性弱视时的全天使用阿托品、间歇性使用阿托品、光学压抑疗法与双眼治疗效果
Ophthalmology. 1997 Dec;104(12):2143-55. doi: 10.1016/s0161-6420(97)30048-7.
9
Identification and treatment of amblyopia.弱视的识别与治疗。
Am Fam Physician. 2013 Mar 1;87(5):348-52.
10
Amblyopia characterization, treatment, and prophylaxis.弱视的特征、治疗与预防。
Surv Ophthalmol. 2005 Mar-Apr;50(2):123-66. doi: 10.1016/j.survophthal.2004.12.005.

引用本文的文献

1
Neurofibromatosis type 2 misdiagnosed as amblyopia-a case report and literature review.2型神经纤维瘤病误诊为弱视——病例报告及文献复习
Front Med (Lausanne). 2025 Aug 7;12:1556494. doi: 10.3389/fmed.2025.1556494. eCollection 2025.